February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...
February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology ...
February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 20, 2024 — X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment ...
February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...
February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...
February 16, 2024 — Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, announced ...
February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...
February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its ...
February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...
February 14, 2024 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that ...
February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...